Byron B Au-Yeung1, Heather J Melichar2, Jenny O Ross3, Debra A Cheng4, Julie Zikherman4, Kevan M Shokat5, Ellen A Robey3, Arthur Weiss4. 1. 1] Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California, USA. [2] Rosalind Russell-Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, California, USA. [3] Department of Medicine, University of California, San Francisco, San Francisco, California, USA. [4] Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. [5]. 2. 1] Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA. [2] [3]. 3. Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, USA. 4. 1] Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California, USA. [2] Rosalind Russell-Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, California, USA. [3] Department of Medicine, University of California, San Francisco, San Francisco, California, USA. [4] Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. 5. 1] Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California, USA. [2] Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.
Abstract
The catalytic activity of Zap70 is crucial for T cell antigen receptor (TCR) signaling, but the quantitative and temporal requirements for its function in thymocyte development are not known. Using a chemical-genetic system to selectively and reversibly inhibit Zap70 catalytic activity in a model of synchronized thymic selection, we showed that CD4(+)CD8(+) thymocytes integrate multiple, transient, Zap70-dependent signals over more than 36 h to reach a cumulative threshold for positive selection, whereas 1 h of signaling was sufficient for negative selection. Titration of Zap70 activity resulted in graded reductions in positive and negative selection but did not decrease the cumulative TCR signals integrated by positively selected OT-I cells, which revealed heterogeneity, even among CD4(+)CD8(+) thymocytes expressing identical TCRs undergoing positive selection.
The catalytic activity of Zap70 is crucial for T cell antigen receptor (TCR) signaling, but the quantitative and temporal requirements for its function in thymocyte development are not known. Using a chemical-genetic system to selectively and reversibly inhibit Zap70 catalytic activity in a model of synchronized thymic selection, we showed that CD4(+)CD8(+) thymocytes integrate multiple, transient, Zap70-dependent signals over more than 36 h to reach a cumulative threshold for positive selection, whereas 1 h of signaling was sufficient for negative selection. Titration of Zap70 activity resulted in graded reductions in positive and negative selection but did not decrease the cumulative TCR signals integrated by positively selected OT-I cells, which revealed heterogeneity, even among CD4(+)CD8(+) thymocytes expressing identical TCRs undergoing positive selection.
The Syk family tyrosine kinases, Zap-70 and Syk, are activated upon TCR engagement
and promote downstream signal transduction essential for T cell development[1-3].
Expression of Zap-70 and Syk varies throughout T cell development, with Syk expressed at
high amounts during β selection whereas Zap-70 is the dominant kinase in DP
cells[4]. In mice, Zap-70 has a
nonredundant role in positive selection; deficiency causes a complete block at the DP stage
and expression of hypomorphic Zap70 alleles impairs positive
selection[5-9].Different experimental models have manipulated Zap-70 expression as a means of
limiting TCR signals during positive selection or to synchronize positive
selection[10,11]. While genetic systems are useful for inducible or developmental
stage-specific expression, it is difficult to titrate or temporally halt Zap-70 expression
with precision. We reasoned that a cell permeable, reversible pharmacologic inhibitor would
enable titration and temporal control of Zap-70 activity to study the requirements for TCR
signaling magnitude and duration for thymic selection. Such control over TCR-derived
Zap-70-dependent signal strength was not previously possible. To inhibit Zap-70 activity, we
developed a chemical-genetic approach in which bulky analogs of the kinase inhibitor PP1
selectively inhibit an “analog-sensitive” mutant of Zap-70 (referred to as
Zap-70(AS)), but not wild-type Zap-70[12]. Activation of primary mouse T cells expressing
Zap70(AS) was sensitive to 3-MB-PP1 in a rapid, reversible, and
dose-dependent manner[13].Here, we use catalytic inhibition of Zap-70 as a method to manipulate the strength
of TCR signaling during T cell development. Our studies focus on the timing and dose of
Zap-70 inhibition. These data provide unanticipated insights regarding the thresholds for
the duration and magnitude of Zap-70 activity required for positive and negative
selection.
Results
Zap-70 and Syk-specific inhibition
We first confirmed the specificity of inhibitors of Zap-70(AS) and Syk.
Consistent with previous studies on mature T cells[13], treatment of thymocytes with the Zap70(AS)-specific
inhibitor, 3-MB-PP1, impaired CD3 crosslinkinginduced increases in cytosolic free
Ca2+ (hereafter referred to as [Ca2+]i) and Erk
phosphorylation in a dose-dependent manner in Zap70(AS), but not control
Zap70 thymocytes that express the wild-type
kinase (Supplementary Fig. 1a,b).
Further, we simultaneously stimulated splenic T cells (expressing Zap-70(AS)) and B cells
(expressing Syk) and detected antigen receptor-induced increases in
[Ca2+]i. Indeed, 3-MB-PP1 treatment impaired increases in
[Ca2+]i induced upon CD3 crosslinking in CD4+ T cells,
but not IgM crosslinking in B cells, suggesting that 3-MB-PP1 specifically inhibits
Zap-70(AS) but not Syk (Supplementary
Fig. 1c). Conversely, treatment with BAY61–3606[14] impaired IgM but not CD3-induced
[Ca2+]i increases, demonstrating the specificity of
BAY61–3606 for Syk and not Zap-70(AS).
Differential importance of Zap-70 versus Syk
One caveat to studying gene knockout models is the possibility of compensatory
mechanisms or artifacts introduced at earlier stages of T cell development in the absence
of Zap-70. Furthermore, catalytic inhibitors enable the interrogation of non-catalytic
functions of Zap-70 to T cell development. Therefore, we revisited the relative functions
of Syk and Zap-70 during β-selection. We performed fetal thymic organ culture
(FTOC) of thymic lobes from embryonic day 15.5 (e15.5)
Zap70 and Zap70(AS) mice in the
presence of 3-MB-PP1 or BAY61–3606. Inhibition of Syk, but not Zap-70, robustly
impaired expression of CD27, a marker associated with the DN3b post-selection population
(Fig. 1a[15]. Syk inhibition also profoundly inhibited the transition from DN3 to
DN4 cells and total thymocyte numbers after 4 days of culture (Fig. 1b,c). Following 4 days of 3-MB-PP1 treatment in FTOC, there was a
~2-fold impairment in the proportion of
CD25−CD44− DN (DN4) cells in 3-MB-PP1- versus
DMSO-(vehicle control) treated FTOCs (Fig. 1b). Total
FTOC cell numbers were decreased in the presence of 3-MB-PP1, but less than with Syk
inhibition (Fig. 1c). The effects of both inhibitors
were additive, such that simultaneous addition resulted in a near complete block in
generation and/or maintenance of DN4 and DP cells (Fig.
1c and Supplementary Fig.
1d).
Figure 1
Greater dependence on catalytic activity of Syk versus Zap-70 for β
selection
(a) FTOC of e15.5 Zap70(AS) thymic lobes was
performed for 4 days with vehicle alone (DMSO), 5 µM 3-MB-PP1, 1 µM
BAY61-3606, or both inhibitors. Overlayed histograms show CD27 expression on gated
CD25+ CD44− DN3 cells from fetal thymic lobes cultured
with the indicated inhibitors. (b) Flow cytometry plots are gated on total
CD4−CD8− DN and TCR γδ negative
cells. The numbers indicate the percentage of cells within each quadrant. (c)
Total cell numbers for a single fetal thymic lobe cultured under the indicated inhibitor
conditions on day 3. Bar graphs display the mean total cell numbers (± s.e.m.)
from three independent experiments. Data in panels (a,b) are from one
representative experiment out of 3 independent experiments. *P
<0.05, **P <0.005, ***P <0.0005,
NS not significant (Student’s t-test).
Zap-70 activity is required for positive selection
To determine the effect of titrating Zap-70 activity on positive selection, we
performed FTOC of e15.5 Zap70(AS) thymic lobes for 5 days with graded
concentrations of 3-MB-PP1. Analysis of total thymocytes showed little apparent inhibitory
effect of 3-MB-PP1 on the frequency of CD4+SP and CD8+SP cells.
However, gating on TCRβhi cells revealed dose-dependent impairment in
development of both populations (Fig. 2a and Supplementary Fig. 2a,b). High
concentrations of 3-MB-PP1 also resulted in an overall decrease in CD5 expression on the
DP population and resulted in the absence of the TCRβhi
CD5hi population that includes cells undergoing positive selection (Fig. 2a). The relative impairment in CD5 expression on DP
cells is consistent with an attenuated magnitude of TCR signaling[16], and coincided with a block in the
generation of CD4+SP and CD8+SP cells with a mature
TCRβhi CD24lo phenotype. Titration of 3-MB-PP1 resulted in
dose-dependent reductions in the percentages of TCRβhi CD5hi
DP cells, as well as mature TCRβhi CD24lo CD4+SP
and CD8+SP cells, suggesting that the capacity of DP cells to complete positive
selection is proportional to the magnitude of Zap-70 dependent signals (Supplementary Fig. 2b,c).
Furthermore, analysis of only the TCRβhi cells revealed that titration
of 3-MB-PP1 inhibited the development of mature CD4+SP and CD8+SP to
a comparable extent, suggesting that Zap-70 catalytic activity is similarly required for
the differentiation of both lineages (Supplementary Fig. 2b,c).
(a)
Zap70(AS) FTOC samples after 5 days of culture in the presence of the
indicated concentrations of 3-MB-PP1. Flow cytometry plots are gated on total viable cells
(top), DP cells (second row), CD4+SP cells (third row), and CD8+SP
cells (bottom row). The numbers indicate the percentage of cells within each gate.
(b) Fetal thymic lobes were cultured in the absence of inhibitor for 4 days
(left column, “before pulse”). On day 4, lobes were cultured with DMSO
only (middle column, “Day 6 DMSO”) or 5 µM 3-MB-PP1 (right column,
“Day 6 3-MB-PP1”) for an additional 48 hand analyzed. Data in
(a) and (b) are representative of 2 and 3 independent
experiments, respectively.
One advantage of small molecule-mediated inhibition over genetic models is the
capacity to rapidly block Zap-70(AS) catalytic activity, independently of the rate of
Zap-70 protein turnover. Previous work demonstrated that addition of 3-MB-PP1 to activated
T cells could decrease [Ca2+]i to baseline levels within one minute
of addition[13]. We next asked how acute
inhibition of Zap-70 activity, after normal T cell development has been initiated, affects
positive selection. To address this question, we performed FTOC of e15.5
Zap70(AS) thymic lobes for 4 days in the absence of inhibitor, followed
by continuous treatment with a high concentration of 3-MB-PP1 or DMSO alone, for 48 hours
(Fig. 2b). After 4 days without inhibitor, there
was a population of TCRβhi CD5hi DP cells, but few mature
single positive cells. On day 6, following a pulse with vehicle alone, there was a 3-fold
increase in the percentage of DP cells with a TCRβhi CD5hi
phenotype, and a marked accumulation of CD24lo CD4+SP and
CD8+SP cells. In contrast, FTOC pulsed with 3-MB-PP1 from days 4–6
had significantly fewer TCRβhi CD5hi DP cells, and decreased
percentages of mature CD24lo SP cells, suggesting that abrupt inhibition of
Zap-70 catalytic activity interrupts positive selection (Supplementary Fig. 2d).
Positive selection in thymic slices requires Zap-70
To more precisely define the temporal signal threshold required for positive
selection, the ability to monitor a cohort of DP cells undergoing relatively synchronous
positive selection is required. We adapted an experimental system in which TCR transgenic
thymocytes from a non-selecting background (pre-selection thymocytes) are added to thymic
tissue slices containing endogenous positive selecting ligands, allowing for a relatively
synchronous wave of positive selection over a period of 2–3 days of
culture[17,18]. To generate pre-selection thymocytes expressing Zap-70(AS), we
reconstituted irradiated β2-microglobulindeficient
(B2m) recipients with
Zap70 OT-I or Zap70(AS) OT-I
TCR transgenic bone marrow. The pre-selection DP cells from the reconstituted mice were
then introduced onto thymic slices from congenic CD45.1+
B2m or WT mice and incubated for up to 72
h. As previously reported[18], mature
CD8+SP thymocytes appeared between 24–72 h of culture, whereas no
detectable CD8+SP cells arose on non-selecting
(B2m−/−) slices (Fig. 3a). Addition of 3-MB-PP1 completely suppressed the appearance of
mature CD8+SP cells. In addition, upregulation of CD5 and CD69 on DP cells
normally observed at 24 h was blocked by Zap-70 inhibition (Fig. 3b).
Figure 3
Positive selection in thymic slices requires Zap-70 catalytic activity
Pre-selection DP cells were generated by transferring bone marrow from
Zap-70(AS) OT-I donor mice into irradiated
B2m recipients. (a)
Pre-selection CD45.2+Zap70(AS) OT-I DP cells were introduced
onto CD45.1+B2m or WT thymic
slices in the presence of DMSO alone or 3-MB-PP1 and analyzed at 24, 48, 60, or 72 hs for
the presence of CD8+SP cells. The percentages of CD8+SP cells were
determined among the CD45.2+ cells, and normalized relative to the average of
the 72hr DMSO samples. The graph displays the average percentage of CD8+SP
(± s.e.m.) from technical triplicate samples. Data are from one representative
experiment out of three independent experiments. (b) Histograms show the
expression of CD5 (top) and CD69 (bottom) on DP cells from panel (a) after 24
h of culture. (c) Graphs show the corrected calcium ratio and interval speed
of two (each panel) representative individual Zap70(AS) OT-I cells
detected by two-photon imaging in WT thymic slices. (d) Each horizontal line
represents an individual Zap70(AS) OT-I cell track within a WT thymic
slice. The arrows represent the time point at which DMSO or 10 µM 3-MB-PP1 was
added to the thymic slices. The black segments represent the time points during which
elevated [Ca2+]i was detected. (e) Imaging data was
converted to dot plot form to display the calcium ratio versus time. Each dot represents a
single time point for each cell. The horizontal red line delineates signaling from
non-signaling cells. The numbers represent the percentage of events with low or high
[Ca2+]i levels within each gate. Imaging data are representative
of three movies from two independent experiments. *P <0.05,
**P <0.005, NS not significant (Student’s
t-test).
We showed previously that OT-I thymocytes in thymic slices undergo transient
signaling events characterized by transient elevations in [Ca2+]i
and migratory pauses[18]. To examine the
impact of Zap-70 inhibition on calcium signals during positive selection, we overlaid OT-I
Zap70(AS) DP thymocytes loaded with a ratiometric Ca2+
indicator dye on thymic slices, and added inhibitor while imaging the cells by two-photon
microscopy (Supplementary Movie 1). In the absence of
inhibitor, thymocytes in WT thymic slices displayed brief (1–10 minutes)
elevations in [Ca2+]i coinciding with migratory pauses (Fig. 3c,d). Plots of calcium ratios for individual time
points show that these events correspond to occasional elevations in
[Ca2+]i with the majority (>70%) of time points
remaining at background levels (Fig. 3e). Within 10
minutes of inhibitor addition, we observed a sharp decrease in the frequency of elevations
in [Ca2+]i, corresponding to the decreased number of time points
displaying elevated [Ca2+]i (Fig.
3d,e). This confirms that addition of inhibitor to thymic slices effectively and
rapidly abrogates the TCR signaling events associated with positive selection. To confirm
the reversibility of Zap-70 inhibition, we also performed inhibitor
“wash-out” experiments, in which Zap70(AS) thymocytes
migrated into the slice in the presence of 3-MB-PP1, and then samples were placed in media
without inhibitor just prior to imaging. Calcium signaling events were detectable 7
minutes after inhibitor removal, and by 2 h, the frequency of cells signaling was
comparable to non-inhibited cells (Supplementary Fig. 3a,b).To more precisely define the temporal requirements for Zap-70 signaling during
positive selection, we added 3-MB-PP1 at different times after initiating the culture
(Fig. 4a). Appreciable accumulation of
CD8+SP cells was only detected under conditions where inhibitor was added
after at least 36 h of culture, in good agreement with the timing of the appearance of
CD8+SP cells (Fig. 3a) and consistent
with inducible Zap-70 expression studies[11]. This indicates that Zap-70 catalytic activity is required at late
stages of positive selection, up to or just before the DP to CD8+ SP
transition.
Figure 4
Temporal and dose-dependent requirements for Zap-70 catalytic activity during
positive selection
(a,b) Pre-selection Zap-70(AS) OT-I DP cells were cultured on WT
thymic slices for a total of 72 h. Schematics on the left indicate the time intervals
during which 2.5 µM 3-MB-PP1 was added (closed bars), or cultured without
inhibitor (open bars). Graphs display the mean percentage (± s.e.m.) of
CD8+SP cells from technical triplicate samples normalized relative to the
DMSO treated control sample. Data in panel (a) are from one representative
experiment out of three independent experiments. Panel (b) displays data
compiled from 5 independent experiments. (c) CD5 expression on DP cells from
panel (b), after 72 h of culture on thymic slices. Data are from one
representative experiment out of three independent experiments. (d)
Pre-selection Zap70 or Zap-70(AS) OT-I DP cells
were introduced onto B2m or WT thymic
slices in the constant presence of the indicated concentrations of 3-MB-PP1 or DMSO alone
for 72 h. Graph shows technical triplicate samples for each condition, and the horizontal
line represents the mean and error bars show (± s.e.m.). (e) CD5
expression on DP cells after 48 h of culture. Data shown in (d) and (e) are from one
representative experiment out of three independent experiments. *P
<0.05, **P <0.005, ***P <0.0005,
NS not significant (Student’s t-test).
However, it was not clear whether the lengthy requirement of signaling for DP
cells to complete positive selection reflected a requirement for continuous
Zap-70-dependent signals. To determine whether a transient interruption of Zap-70 activity
would affect the completion of positive selection, we inhibited Zap-70 catalytic function
for 12-h time periods with a high concentration of 3-MB-PP1 (2.5 µM) followed by a
chase with vehicle alone to reverse Zap-70 inhibition (Fig.
4b). The inhibitor pulses were performed in consecutive 12-h blocks covering 0 to
72 h. The feasibility of such an experiment is possible because the effects of 3-MB-PP1 on
TCR signaling are rapidly reversible (Supplementary Fig. 3a,b)[13].
Addition of 3-MB-PP1 between 0–12 h or 60–72 h had moderate inhibitory
effects on the appearance of CD8+SP cells, correlating with the two conditions
that had the longest intervals (60 hours) of uninterrupted Zap-70 activity. In contrast,
12-h periods of Zap-70 catalytic inhibition, especially between 12 and 48 h all resulted
in markedly impaired generation of CD8+SP cells, despite an identical aggregate
of 60 h of uninhibited Zap-70 activity. Additionally, CD5 expression on DP cells was
comparably reduced among all samples that were exposed to 3-MB-PP1 for 12-h intervals
(Fig. 4c). These results strongly imply that robust
positive selection has a temporal TCR-Zap-70 signaling requirement, consisting of a
minimum of 36 h of continuous Zap-70 activity.In addition to the temporal requirement for Zap-70-dependent TCR signaling, we
probed the strength of TCR signaling required for efficient positive selection. To do so,
we exposed thymic slices containing OT-I Zap70(AS) DP thymocytes to
various concentrations of 3-MB-PP1. Titration of 3-MB-PP1 concentration resulted in a
graded, dose-dependent reduction in the percentage of OT-I CD8+SP cells, with
concomitant shifts in CD5 expression (Fig. 4d,e).
These data reveal that even modest inhibition of TCR signal strength significantly impairs
positive selection. Moreover, DP cells with the same TCR behave heterogeneously in
response to varying the strength of TCR/Zap-70 dependent signals.
Integration of TCR signaling during positive selection
The requirement for TCR signaling over an extended time-period, together with
the brief duration of TCR signaling events in individual cells undergoing positive
selection, implied that thymocytes might be summing TCR signals from transient serial
encounters over a period of days to reach a cumulative TCR signaling threshold for
positive selection. To visualize the cumulative TCR signals associated with positive
selection, we took advantage of a Nur77-GFP transgene which reports on the relative
“strength” of antigen receptor signaling perceived at a single-cell
level[19]. By combining both the
Zap-70(AS) and the Nur77-GFP systems we simultaneously titrated Zap-70 catalytic activity
with an inhibitor, and indirectly measured the accumulation of downstream signals in
response to TCR stimulation by the accumulation of GFP fluorescence intensity.To demonstrate this capacity, we stimulated OT-I pre-selection
Zap70(AS)-Nur77-GFP DP thymocytes with graded concentrations of
anti-CD3 or with a single concentration of anti-CD3 plus graded concentrations of 3-MB-PP1
(Supplementary Fig. 4a). As
expected, titration of anti-CD3 or 3-MB-PP1 resulted in dose-dependent reductions in the
proportion of cells that induced GFP expression. For anti-CD3 stimulation, the
fluorescence intensity of the responding cells was not dependent on the magnitude of
stimulus, consistent with other studies showing that mature T cells make a digital
response to limited TCR triggering[20]. In
contrast, the GFP mean fluorescence intensity of the responding cells was dependent on the
concentration of 3-MB-PPI. These data demonstrate that, while varying TCR triggering at
the membrane leads to a digital “off/on” response in thymocytes, titration
of Zap-70 catalytic activity provides a means to control the level of TCR signaling
experienced by individual cells in an analog fashion.To determine whether the GFP fluorescence intensity induced during positive
selection is at “saturating” levels, we analyzed DP thymocytes from WT and
Bim-deficient Nur77-GFP mice. Comparison of pre-selection (TCRβlo
CD69lo) and post-selection (TCRβhi CD69hi) DP
cells within each genotype revealed elevated GFP fluorescence in the post-selection
population (Supplemetary Fig. 4b). Further comparison
of WT and Bim post-selection DP cells
showed skewing toward a higher GFP fluorescence intensity in the absence of Bim,
consistent with stronger TCR signals experienced by cells rescued from negative
selection[21] (Supplementary Fig. 4c). These results
indicate that GFP fluorescence associated with positive selection is within the dynamic
range of the Nur77-GFP reporter and does faithfully report on TCR signal strength.To determine the effects of titration of Zap-70 catalytic activity on TCR signal
integration during positive selection, we added various concentrations of the 3-MB-PPI to
OT-I Zap70(AS)-Nur77-GFP DP cells under positive selection conditions.
Interestingly, while 3-MB-PP1 titration led to a dose-dependent reduction in
CD8+SP frequency, it had little effect on GFP fluorescence intensity among
the CD8+SP populations generated (Fig.
5a,b). Given evidence that 3-MB-PPI titration leads to an analog reduction in TCR
signaling in individual thymocytes (Supplementary Fig. 4a), these data imply that dampening the magnitude of
TCR-Zap-70 dependent signals reduces the proportion of thymocytes that reach a cumulative
TCR signal threshold for positive selection, but does not shift the TCR signal threshold
itself. Moreover, these results point to heterogeneity of thymocytes in their ability to
accumulate TCR signals, even when all cells express the same TCR.
Figure 5
Invariant Zap-70 dependent signal threshold for positive selection
(a) Pre-selection OT-I Zap-70(AS)-Nur77-GFP DP cells were cultured
on WT thymic slices for 72 hours in the presence of the indicated concentrations of
3-MB-PP1. Graph displays the average percentage of CD8+SP (± s.e.m.)
from technical triplicate samples detected at 72 hours, normalized to the average of the
DMSO only control samples.(b) Histograms show GFP expression by the
CD8+SP populations from indicated inhibitor treatment conditions. Closed gray
histogram shows the GFP expression on DP cells cultured on non-selecting
B2m thymic slices. (c)
Zap-70(AS)-Nur77-GFP thymic lobes were cultured for 7 days in the presence of the
indicated concentrations of 3-MB-PP1. Flow cytometry plots are gated on DP cells and the
numbers indicate the percentage of cells within the TCRβhi
CD69+ population (top). Histograms show GFP expression of
TCRβ− CD69− DP cells (black) versus
TCRβhi CD69+ cells (red) (bottom). (d) GFP
expression of the TCRβhi CD69+ cells from
Zap-70(AS)-Nur77-GFP FTOC. Data from (a,b) are representative of 2
independent experiments. Data from (c,d) are representative of 3 independent
experiments. *P <0.05, **P <0.0005, NS
not significant (Student’s t-test).
To further explore the impact of Zap-70 activity titration on positive
selection, we cultured polyclonal e15.5 Zap70(AS)-Nur77-GFP fetal thymic
lobes in the constant presence of different concentrations of 3-MB-PP1. Consistent with
results of the Zap70(AS) FTOC and thymic slice experiments, titration of
3-MB-PP1 resulted in a dose-dependent reduction in the percentage of
TCRβhiCD69+ DP cells (Fig.
5c, top row). Comparison of the CD69− and CD69+ DP
populations in FTOC treated with DMSO revealed elevated GFP fluorescence only in the
CD69+ cells (Fig. 5c, bottom row).
Further analysis of the TCRβhiCD69+ cell subpopulation
showed that the mean fluorescence intensity of GFP was not influenced by the concentration
of 3-MB-PP1 (Fig. 5d). To support this observation,
DP cells were re-examined based on TCRβ−CD5lo (DP1),
TCRβintCD5hi (DP2), and
TCRβhiCD5hi (DP3) subsets, transitional stages through
which DP cells pass during positive selection[11]. Consistent with the effects of Zap-70 inhibition on CD69 expression,
the presence of 3-MB-PP1 resulted in fewer DP2 and DP3 cells; however, DP3 cells exposed
to different concentrations of 3-MB-PP1 had comparable GFP fluorescence (Supplementary Fig. 4e). These data
imply that titration of Zap-70 activity reduces the proportion of thymocytes that receive
sufficient signals to undergo positive selection. However, those few cells that still
undergo positive selection have attained a level of cumulative TCR signaling that is
similar to cells that undergo positive selection in the absence of Zap-70 inhibition.
Requirements for Zap-70 during negative selection
The temporal TCR signaling requirements for negative selection, were studied by
inducing a synchronous wave of negative selection by introducing pre-selection
Zap70(AS) or Zap70 OT-I DP cells
onto WT thymic slices with cognate OVA (ovalbumin 257–264) peptide. To
quantitatively assess negative selection, we co-introduced F5 thymocytes which are
positively selected in this system. We then quantified negative selection as a decrease in
the ratio of viable OT-I DP cells to F5 cells. Within 24 h after addition of OVA peptide
to the slices in the absence of any inhibitors, there was a significant decrease in the
normalized ratio of OT-I to F5 cells from 1 to ~0.25 (Fig. 6a and Supplementary Fig. 5a). The surviving viable OT-I cells expressed elevated
levels of CD69 (Fig. 6b).
Figure 6
Negative selection requires Zap-70 catalytic activity in a dose and time-dependent
manner
Pre-selection CD45.2+Zap70 or
Zap70(AS) OT-I DP cells were co-transferred with dye-labeled,
CD45.2+ F5 TCR DP cells at a 1:1 ratio, onto CD45.1+ WT thymic
slices. Slices were then cultured with or without 0.1 nM OVA peptide to induce negative
selection. All graphs in this figure display the technical triplicate samples for each
condition, with the horizontal line representing the mean OT-I: F5 ratio (±
s.e.m.), normalized to the average ratio from the control samples, specified below.
(a) After 24 h of culture with constant exposure to the indicated
inhibitors, slices were analyzed for the ratio of viable OT-I cells to F5 cells. Ratios
were normalized to the control sample (DMSO alone, 0 nM OVA). Inhibitor concentrations:
3-MB-PP1 (5 µM), HXJ42 (1 µM), BAY61-3606 (1 µM). (b)
Histograms show CD69 expression on viable DP cells from slices cultured with the indicated
inhibitors. (c) Zap-70(AS) OT-I DP thymocytes were cultured on
B2m−/− or WT thymic slices with OVA and
analyzed at the indicated time points. Ratios were normalized to the 0 hr samples.
(d) Histogram shows CD69 expression on viable DP cells at each indicated
time point. (e) HXJ42 (1 µM) was added to thymic slices at the
indicated times after co-introduction of pre-selection OT-I thymocytes and OVA peptide.
Ratios were normalized to the average of the (DMSO, 0 nM OVA) control samples. Horizontal
bars represent the average of technical triplicate samples (± s.e.m.).
(f) Histogram shows CD69 expression on viable DP cells at 24 h.
(g) Zap-70(AS) OT-I DP thymocytes were cultured on WT thymic slices for 24
h with OVA in the presence of the indicated concentrations of HXJ42. Horizontal bars
represent the average of technical triplicate samples (± s.e.m.). Ratios were
normalized to the average of the (DMSO, 0 nM OVA) control samples. All panels show data
from one representative experiment out of 3 independent experiments. *P
<0.05, **P <0.005, ***P <0.0005,
NS not significant (Student’s t-test).
We predicted that addition of 3-MB-PP1 to this experimental system would enable
the rescue of Zap70(AS) DP cells from negative selection. However,
contrary to our prediction, addition of a high concentration of 3-MB-PP1 did not
substantially increase the ratio of viable OT-I DP cells to F5 cells relative to addition
of DMSO alone or a Syk inhibitor (Fig. 6a). We
hypothesized that the potency of 3-MB-PP1 was not sufficient to dampen downstream TCR
signals enough to rescue deletion. Therefore, we used an alternative PP1 analog (HXJ42),
which has greater selectivity and potency for Zap-70(AS) over wild-type Zap-70, as
assessed by Erk and Lat phosphorylation, as well as by proliferative responses of mature
CD4+ cells (Supplementary Fig.
5b,c,d). Consistent with its more potent inhibitory effect on Zap-70(AS)
kinase-dependent signals, addition of HXJ42 more effectively rescued
Zap70(AS) OT-I cells from negative selection. Additionally, the
majority of remaining viable Zap70(AS) OT-I cells in HXJ42-treated thymic
slices did not highly express CD69, suggesting an efficient block in TCR signals that
drive negative selection (Fig. 6b).We assessed the tme-dependency of deletion in this system, by examining the OT-I
to F5 ratio over time (Fig. 6c). A relative decrease
in OT-I abundance was detectable between 6 and 9 h, consistent with the kinetics of
negative selection in previous studies[22]. Additionally, upregulation of CD69 expression was detectable by 3 h,
with the majority of remaining viable cells staining positive for CD69 by 6 h (Fig. 6d). Addition of a high concentration of HXJ42 (1
µM) to WT thymic slices with Zap70(AS) OT-I cells concurrently
with OVA peptide resulted in a nearly complete block in deletion. However, a substantial
proportion of OT-I DP cells was deleted if addition of HXJ42 was delayed by one hour after
the OVA peptide (Fig. 6e). Addition of HXJ42 from
3–9 h after the OVA peptide resulted in increased negative selection and
approached deletion comparable to treatment with vehicle alone. These data imply that a
short duration of Zap-70 dependent signaling is sufficient for deletion, but prolonged
signaling (up to 9 h) increases the efficiency of negative selection. The shorter period
of TCR signaling required for negative selection when compared to positive selection is
consistent with the more intense and prolonged [Ca2+]i increase
observed during negative selection as compared to positive selection (Supplementary Fig. 5e)[18].To determine whether there is a Zap-70 dependent signal threshold for negative
selection, we incubated Zap70(AS) OT-I DP cells in WT slices with OVA and
graded concentrations of HXJ42. Although high concentrations of HXJ42 (1.0, 2.0
µM) blocked negative selection and low concentrations (0.3, 0.6 µM) did
not prevent negative selection, intermediate concentrations of HXJ42 weakly inhibited
negative selection in a dose-dependent manner (Fig.
6f). This dosedependency was also reflected by CD69 expression on the remaining
viable DP cells after 24 hours, such that increasing the inhibitor concentration resulted
in decreased CD69 expression (Fig. 6g). These studies
suggest that even with a fixed TCR repertoire and a single agonist peptide, heterogeneity
in responsiveness to titration of TCR signaling intensity is observed at the population
level.
Discussion
How TCR recognition of self-peptide-MHC can lead to either positive or negative
selection is a question that has long attracted the attention of immunologists, with most
explanations focusing on differences in TCR signal strength. A resolution to this question
has proved elusive, in part due to the inability to precisely determine the quantitative and
temporal requirements for TCR signaling for positive and negative selection of thymocytes.
Since Zap-70 catalytic function is required for nearly all TCR signal propagation, its
activity should be reflective of strength of TCR signaling. Here we use a genetically
selective pharmacologic inhibitor of Zap-70(AS) as a means of controlling TCR signal
transduction quantitatively and temporally in DP thymocytes within living, three-dimensional
thymic tissue. We show that while thymocytes can commit to negative selection after only one
hour of TCR signaling, completion of positive selection requires a minimum duration of 36 h
of TCR signaling, in line with previous studies[10,21-24]. Our data indicate that models to explain positive versus
negative selection based on TCR signal strength alone are insufficient, and that the
temporal pattern and cumulative TCR signaling may be as important as the quantity of TCR
signal.The distinct temporal and quantitative requirement for TCR signaling between
positive and negative selection reported here fits well with the dynamics of individual
TCR-dependent calcium signaling events reported previously[18,22]. Encounter with
negative selecting ligands led to prolonged migratory arrest and sustained elevations in
[Ca2+]i, a pattern of TCR signaling that would allow for rapid
accumulation of TCR signaling intermediates, and thus account for the relatively brief
period of TCR signaling required for a thymocyte to commit to die. On the other hand,
encounter with positive selecting ligands was associated with brief, weak, and discontinuous
[Ca2+]i increases interspersed with periods of migration[18]. These observations, together with evidence
presented here that positive selection requires many hours of uninterrupted Zap-70 activity.
Thymocytes must accumulate sufficient TCR signaling to overcome a fixed threshold,
suggesting that DP cells can “remember” and integrate recent TCR signaling
events over time to reach a signal threshold required for positive selection. The mechanisms
responsible for the integration of TCR signaling leading to positive selection remain
unclear, but may involve the accumulation of relatively stable signaling
intermediates[25,26]. Given the prolonged time required for this cumulative
signaling integration, distinct developmental stages driven by an ordered cascade of
transcriptional events might also be involved. There is evidence that genes that are
differentially regulated during the DP substages of development could reflect such ordered
or sequential transcriptional changes[27].Our results provide new insights regarding the quantitative requirements for TCR
signal strength between positive versus negative selection. In particular, while positive
selection can be completely blocked using the moderately potent inhibitor 3-MB-PP1,
inhibition of negative selection requires the more potent inhibitor HXJ42. This difference
implies that the level of Zap-70-dependent TCR signal induced by negative selecting ligands
is in substantial excess over that required to induce thymocyte death. In contrast, modest
Zap-70 inhibition leads to a profound block in positive selection. This quantitative
difference in the requirement for Zap-70 activity also fits with the temporal pattern of TCR
signaling. During negative selection, thymocytes arrest and can continue to accumulate TCR
signals until they achieve a sufficient amount of TCR signaling for negative selection. In
contrast, modest inhibition of Zap-70 during positive selection may disrupt the TCR
“signal memory” required for positive selection by reducing the intensity,
frequency, or duration of transient signaling events.In spite of the distinct thresholds involved, titration of Zap-70 activity led to
a graded inhibition of both positive and negative selection. This suggests heterogeneity
amongst DP thymocytes, even if they express a fixed TCR. This heterogeneity may reflect the
stochastic nature of thymocyte encounters with selecting ligands. Alternatively, stochastic
variations in the expression of TCR signaling proteins may render certain thymocytes more or
less resistant to Zap-70 inhibition.The graded inhibition of positive or negative selection observed upon quantitative
reduction of Zap-70 catalytic activity is in contrast to the sharp threshold for positive
versus negative selection observed upon varying affinities of altered peptide ligands-MHC
for TCR[28]. In that study, the altered
affinities change kinetic parameters of TCR: peptide-MHC engagement. Our experimental system
focuses on inhibition of Zap-70 catalytic activity, which is proximal to the TCR, but is
nevertheless activated downstream of TCR engagement. We speculate that the amount by which
TCR signaling is perturbed may be a crucial factor in determining the quality of the output
of downstream signals.Our results with Syk and Zap-70(AS) catalytic inhibitors largely recapitulate the
developmental impairments observed with Syk and Zap70 gene
knockout T cells prior to the DP stage, with Syk catalytic activity predominating at the
β-selection checkpoint, and Zap-70 activity being more important for the generation
or maintenance of DN4 and DP cells. The similarity of phenotypes between knockout and
inhibitor studies suggests that the functions of Zap-70 and Syk during T cell development
require catalytic activity and argues against any prominent role for a non-catalytic
function of either kinase or for compensatory changes. These observations raise the question
of why a switch from Syk to Zap-70 is necessary. One important difference between the two
kinases is that Syk, unlike Zap-70, has the capacity to phosphorylate ITAMs even in the
absence of Src kinase activity[29,30]. Moreover, Zap-70 activation is more dependent
on Src kinases than is Syk since Zap-70 is more subject to autoinhibitory control[31,32]. We
propose that the Syk to Zap-70 transition in thymic development is consistent with a model
whereby coreceptor-mediated recruitment of the Src kinase Lck to the TCR complex becomes a
critical factor in enforcing MHC restriction on developing αβ T
cells[33]. Thus, Syk expression could
facilitate pre-TCR signal transduction in the absence of coreceptor-mediated Lck recruitment
in DN cells. Conversely, expression of Zap-70, as occurs in DP cells, would render these
cells highly dependent upon coreceptor binding to MHC and Lck recruitment for
phosphorylation of TCR associated ITAMs to propagate downstream signals.The temporal and quantitative control and the rapid reversibility of inhibitor
effects, as exemplified in these studies, may allow for opportunities to titrate or
synchronize developmental events and transitions allowing for further insights into complex
events not possible during asynchronous events that occur at a population level.
Online Methods
Mice
Mice used in these studies were housed in the specific pathogen-free facility at
the University of California, San Francisco, and were treated according to protocols
approved by the Institutional Animal Care and Use Committee in accordance with NIH
guidelines. Zap70 were generated by interbreeding
wild-type C57BL/6 mice with Zap-70 deficient
B6.129×1-Zap70 mice.
B6.Cg-Tg(Zap70*M413A)2Weis (referred to as Zap70(AS)) mice were described
previously[13].
Zap70(AS) mice crossed to TCRα-deficient
B6.129S2-Tcra/J, OT-I TCR transgenic
C57BL/6-Tg(TcraTcrb)1100Mjb/J strains (Jackson) or to Nur-77-GFP transgenic mice described
previously[19]. Bim-deficient
B6.129S1-Bcl2l11/J (Jackson) were also crossed to
Nur77-GFP mice. Bone marrow chimeras were generated by transferring bone marrow into
irradiated β2mdeficient, B6.129P2-B2/J mice
(Jackson).
Reagents
Zap-70(AS) Inhibitor compounds 3-MB-PP1 and HXJ42 have been described
previously[12,34]. Syk inhibitor BAY61–3606 was purchased from Sigma.
For positive selection experiments on thymic slices, 2.5 µM 3-MB-PP1 was used and
for negative selection experiments on thymic slices, 5 µM 3MBPP1, 1 µM
HXJ42, or 1 µM BAY61–3606 inhibitor were used unless otherwise
indicated.
FTOC
Timed breedings were performed and fetal thymic lobes were harvested from
embryonic day 15.5 (e15.5) mice. Lobes were cultured on 0.4 µm pore cell culture
inserts (Costar) in 6-well culture dishes atop 1 ml complete DMEM with 10% fetal
bovine serum containing DMSO alone, 3-MB-PP1, or BAY61–3606. Media was exchanged
daily or as indicated until lobes were dissociated into single cell suspensions for
staining with antibodies for flow cytometric analysis.
Bone marrow chimeras
At least 1 × 106 bone marrow cells were transferred to
lethally irradiated (1200 rad) recipient
B2m mice. Pre-selection thymocytes from
chimeras were harvested at least five weeks after bone marrow transplantation.
Thymic slices
Thymic slices were prepared essentially as previously described[35]. Individual thymic lobes from CD45.1 or
B2m CD45.1 congenic mice were embedded
in 4% GTG-NuSieve Agarose (Lonza) in HBSS and cut to a thickness of 400 µm
for flow cytometry experiments or 500µm for two-photon microscopy experiments
using a Vibratome 100 Plus Sectioning System and feather blades (Leica Microsystems).
Thymic slices were maintained on 0.4µm cell culture inserts (BD Biosciences) atop
1 ml complete DMEM media with 10% fetal bovine serum containing DMSO alone or
inhibitors in a 37°C incubator. For positive selection experiments, 3 ×
106 pre-selection OT-I Zap70 or
Zap-70(AS) thymocytes in 10 µL were overlaid on thymic slices. For negative
selection experiments, 1 × 106 of each pre-selection F5
Rag1GFP+
and OT-I thymocytes labeled with 1 µM Cell Proliferation Dye eFluor 670
(eBioscience) in 10 µL were overlaid on thymic slices. Cells were allowed to
migrate into the tissue for two hours before excess cells were removed by indirect
pipetting of media to wash the slices. For negative selection experiments, thymocytes were
allowed to migrate into the tissue for two hours, washed, and the media beneath the
transwell was subsequently changed to media containing 0.1 nM OVA (257–264)
peptide (Anaspec) with inhibitors. Media was exchanged daily or as indicated. For
two-photon microscopy experiments, thymocytes were pre-labeled with 2 µM Indo-1 LR
(Teflabs) for ninety minutes at 37°C and subsequently allowed to recover for an
additional sixty minutes before addition to thymic slices. Thymic slices were affixed to a
coverslip with tissue glue (3M Vetbond) prior to imaging.
Flow cytometry
FTOCs or thymic slices were dissociated into single cell suspensions, filtered,
and stained with antibodies for cell surface markers. The following antibodies were used
for FTOC samples: CD5-FITC (clone 53-7.3) and CD44-PE-Cy7 (clone IM7) from BD Biosciences;
TCRβ-APC (clone H57–597), CD24-Pacific Blue (clone M1/69), and
TCRγδ-PerCPCy5.5 (clone GL3) from BioLegend; CD25-PE (clone PC61.5) and
CD8α-APC-eFluor780 (clone 53-6.7) from eBioscience, and CD4-Qdot605 (clone RM4.5)
from Life Technologies. The following antibodies were used for thymic slice samples:
CD45.1-FITC (clone A20), CD69-PerCPCy5.5 (clone H1.2F3), CD5-PE (clone 53-7.3), CD4-PE-Cy7
(clone RM4–5), CD8α-eFluor450 (clone 53-6.7) from eBioscience. For
negative selection experiments, cells were pre-stained with LIVE/DEAD Fixable Aqua Dead
Cell Stain kit (Molecular Probes) for thirty minutes in PBS. Data were acquired on an
LSRII or LSR Fortessa (BD Biosciences) and analyzed using FlowJo software (Tree Star).
T and B cell cross-linking calcium experiments
Splenocytes from Zap70 and Zap-70(AS)
mice were loaded with the calcium indicator dye Indo-1 (Invitrogen). Labeled cells were
analyzed with a LSR Fortessa cytometer with a UV 355 nm laser (BD Biosciences). Baseline
[Ca2+]i measurements were acquired for thirty seconds, followed by
addition of soluble anti-CD3ε (clone 2C11) and inhibitor for thirty seconds, then
followed by addition of polyclonal goat anti-Armenian hamster antibodies for CD3
crosslinking and polyclonal anti-IgM F(ab’)2 antibodies (both from
Jackson Immunoresearch) for BCR crosslinking. The mean ratio of Indo-(violet) to
Indo-(blue) over time was calculated using FlowJo software (Tree Star).
Two-photon microscopy
Thymic slices were continually perfused with 37°C, oxygenated,
phenol-red free DMEM (Gibco) during image acquisition. Images were acquired in the cortex,
as determined by proximity to the capsule, using a custom built, up-right two-photon
microscope with a 20X/0.95 objective (Olympus). The Ti:Sapphire MaiTai laser
(Spectra-Physics) was tuned to 720 nm and fluorescence collected using 440 nm and 510 nm
dichroic mirrors with 400/45 and 480/50 bandpass filters. 173 × 142µm
images were collected every twenty seconds for ten to forty minutes at 3 µm
z-intervals starting beneath the tissue cut site using custom software.
For addition of DMSO or inhibitor while imaging, the perfusing media was switched after
ten minutes of imaging to media containing 10 µM 3-MB-PP1 or DMSO.
Immunoblot analysis
SDS PAGE and western blot analyses of phosphorylated Tyrosine 132 of Lat and
phosphorylated Threonine 202/Tyrosine204 of Erk in
Zap70 and Zap-70(AS) thymocytes were performed as
previously described[13]. Briefly,
thymocytes were stimulated with soluble anti-CD3ε (clone 145-2C11) and
crosslinking goat anti-Armenian hamster IgG antibodies (catalog#
127-005–099) from Jackson Immunoresearch for two minutes and lysed in SDS lysis
buffer. Whole cell lysates were analyzed by western blot with primary antibodies against
phospho-Lat Y132 (catalog# 44224) from Life Technologies, phospho-Erk T202/Y204
(clone 197G2) from Cell Signaling, or Actin (catalog #A2066) from Sigma, and goat
anti-rabbit IgG-HRP (catalog# 4050-05) secondary antibodies from Southern
Biotech.
Data and statistical analysis
Image analysis was performed using Imaris (Bitplane) software to determine x, y,
and z coordinates as well as mean fluorescence intensities for calcium-bound and
calcium-free Indo-1 LR dye of individual cells over time. The data was processed using
custom written MATLAB scripts (Mathworks), Image J, and Excel programs (Supplemental ___).
To determine corrected calcium values to determine signaling cells, 0.675 (the historical
average value of OT-I cells under non-selecting conditions) was subtracted from raw
fluorescence values, and cells were considered to be signaling when corrected calcium
values were ≥ 0.2 for at least 1 time point of a cell track. Imaging data was
converted to flow cytometry-like files using custom DISCit software for
further analysis with FlowJo software (Tree Star)[36].No statistical tests were used to pre-determine experimental sample size. Sample
sizes were determined empirically for sufficient statistical power. We did not exclude
samples from analysis, and our analyses did not include randomized samples or blinding.
Prism software (GraphPad software) was used for statistical analysis. Statistical
significance between groups was determined by unpaired two-tailed Student’s
t-test. A P-value of less than 0.05 was considered
statistically significant. Statistical analysis was performed on sample groups with
similar variance. Limited variance was observed within sample groups.
Authors: Mark A Daniels; Emma Teixeiro; Jason Gill; Barbara Hausmann; Dominique Roubaty; Kaisa Holmberg; Guy Werlen; Georg A Holländer; Nicholas R J Gascoigne; Ed Palmer Journal: Nature Date: 2006-11-01 Impact factor: 49.962
Authors: D L Wiest; J M Ashe; T K Howcroft; H M Lee; D M Kemper; I Negishi; D S Singer; A Singer; R Abe Journal: Immunity Date: 1997-06 Impact factor: 31.745
Authors: T A Kadlecek; N S van Oers; L Lefrancois; S Olson; D Finlay; D H Chu; K Connolly; N Killeen; A Weiss Journal: J Immunol Date: 1998-11-01 Impact factor: 5.422
Authors: Byron B Au-Yeung; Sebastian Deindl; Lih-Yun Hsu; Emil H Palacios; Susan E Levin; John Kuriyan; Arthur Weiss Journal: Immunol Rev Date: 2009-03 Impact factor: 12.988
Authors: Owen M Siggs; Lisa A Miosge; Adèle L Yates; Edyta M Kucharska; Daniel Sheahan; Tomas Brdicka; Arthur Weiss; Adrian Liston; Christopher C Goodnow Journal: Immunity Date: 2007-12 Impact factor: 31.745
Authors: Byron B Au-Yeung; Susan E Levin; Chao Zhang; Lih-Yun Hsu; Debra A Cheng; Nigel Killeen; Kevan M Shokat; Arthur Weiss Journal: Nat Immunol Date: 2010-10-31 Impact factor: 25.606
Authors: Hanna Sjölin Goodfellow; Maria P Frushicheva; Qinqin Ji; Arup K Chakraborty; Arthur Salomon; Arthur Weiss; Debra A Cheng; Theresa A Kadlecek; Aaron J Cantor; John Kuriyan Journal: Sci Signal Date: 2015-05-19 Impact factor: 8.192
Authors: Jenny O Ross; Heather J Melichar; Byron B Au-Yeung; Paul Herzmark; Arthur Weiss; Ellen A Robey Journal: Proc Natl Acad Sci U S A Date: 2014-06-09 Impact factor: 11.205
Authors: Byron B Au-Yeung; Julie Zikherman; James L Mueller; Judith F Ashouri; Mehrdad Matloubian; Debra A Cheng; Yiling Chen; Kevan M Shokat; Arthur Weiss Journal: Proc Natl Acad Sci U S A Date: 2014-08-18 Impact factor: 11.205
Authors: Jiji Xie; Xuemei Han; Chensi Zhao; Ann J Canonigo-Balancio; John R Yates; Yingqiu Li; Björn F Lillemeier; Amnon Altman Journal: Sci Signal Date: 2019-04-16 Impact factor: 8.192